Top Markets
Coin of the day
Stella Pharma Corporation Stella Pharma Corporation

Stella Pharma Corporation

4888
Clasificación en acciones #22897
Stella Pharma Corporation is a pharmaceutical company that handles the complete... Stella Pharma Corporation is a pharmaceutical company that handles the complete process of drug development, from research and manufacturing to distribution. A core area of its specialization is in therapeutic agents for boron neutron capture therapy (BNCT). Their product lineup includes SPM-011, a boron-containing drug designed for BNCT, which is utilized in the treatment of head and neck cancer, recurrent malignant glioma, meningioma, malignant melanoma, and angiosarcoma. Founded in 2007, Stella Pharma Corporation maintains its headquarters in Osaka, Japan.
Precio por acción
$2.26
Última sincronización: 2026-08-21
Capitalización bursátil
$81.55M
Cambio (1 día)
-0.86%
Cambio (1 año)
-18.45%
País
JP
Comercio Stella Pharma Corporation (4888)

Categoría

Ratio P/B de Stella Pharma Corporation (4888)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Stella Pharma Corporation, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Stella Pharma Corporation desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH